|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,032.00 DKK | -1.45% |
|
-0.34% | +36.15% |
| Dec. 04 | Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM | |
| Dec. 04 | Genmab Closes $2.5 Billion Senior Notes Offering | MT |
| Capitalization | 125B 19.5B 16.76B 15.7B 14.63B 27.03B 1,755B 29.4B 184B 70.9B 829B 73.17B 71.61B 3,030B | P/E ratio 2025 * |
17.4x | P/E ratio 2026 * | 19.2x |
|---|---|---|---|---|---|
| Enterprise value | 102B 15.91B 13.68B 12.81B 11.94B 22.06B 1,432B 23.99B 150B 57.87B 676B 59.72B 58.45B 2,473B | EV / Sales 2025 * |
4.28x | EV / Sales 2026 * | 3.39x |
| Free-Float |
95.94% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Genmab A/S
| 1 day | -1.45% | ||
| 1 week | -0.34% | ||
| Current month | -0.34% | ||
| 1 month | +10.49% | ||
| 3 months | +16.01% | ||
| 6 months | +41.26% | ||
| Current year | +36.15% |
| 1 week | 1,989 |  | 2,111 |
| 1 month | 1,807 | | 2,111 |
| Current year | 1,157 | | 2,153 |
| 1 year | 1,157 | | 2,153 |
| 3 years | 1,157 | | 3,287 |
| 5 years | 1,157 | | 3,327 |
| 10 years | 605.5 | | 3,327 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2010-05-31 | |
Anthony Pagano
DFI | Director of Finance/CFO | 47 | 2020-02-29 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 2024-08-15 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 2003-10-31 | |
| Director/Board Member | 58 | 2014-12-31 | |
| Director/Board Member | 74 | 2014-12-31 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 3.64% | 1,412 M€ | +0.52% | - |
| 0.75% | 26 M€ | +11.73% | - |
| 0.56% | 1,101 M€ | +9.18% | - |
| 0.45% | 31 M€ | +3.89% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.45% | -0.34% | +30.97% | -37.78% | 19.5B | |
| -2.68% | -1.46% | +30.24% | +105.16% | 54.89B | |
| -0.51% | -1.81% | +170.81% | +925.64% | 43.51B | |
| +0.90% | -0.87% | +75.84% | +15.31% | 38.12B | |
| +0.26% | -6.69% | -19.01% | -42.27% | 23.14B | |
| -0.97% | +4.69% | +98.42% | -40.74% | 17.25B | |
| +0.57% | +0.98% | +89.61% | +302.27% | 14.68B | |
| -2.66% | +2.35% | +4.51% | +2,232.48% | 14.12B | |
| +2.45% | +0.79% | +147.98% | - | 13.78B | |
| -1.52% | -3.30% | +84.41% | +692.23% | 13.11B | |
| Average | -0.56% | -0.68% | +71.38% | +461.37% | 25.21B | |
| Weighted average by Cap. | -0.75% | -1.20% | +72.86% | +374.47% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 23.89B 3.72B 3.2B 3B 2.79B 5.16B 335B 5.61B 35.05B 13.53B 158B 13.97B 13.67B 578B | 27.62B 4.3B 3.7B 3.46B 3.23B 5.96B 387B 6.49B 40.51B 15.64B 183B 16.14B 15.8B 669B |
| Net income | 7.5B 1.17B 1B 941M 877M 1.62B 105B 1.76B 11.01B 4.25B 49.69B 4.39B 4.29B 182B | 6.92B 1.08B 927M 868M 809M 1.49B 97.02B 1.63B 10.15B 3.92B 45.82B 4.05B 3.96B 168B |
| Net Debt | -23.01B -3.58B -3.08B -2.89B -2.69B -4.97B -323B -5.4B -33.76B -13.03B -152B -13.45B -13.16B -557B | -31.55B -4.91B -4.22B -3.96B -3.69B -6.81B -442B -7.41B -46.29B -17.87B -209B -18.44B -18.05B -764B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-05 | 2,032.00 kr | -1.45% | 48,388 |
| 25-12-04 | 2,062.00 kr | +1.93% | 94,077 |
| 25-12-03 | 2,023.00 kr | -0.54% | 65,966 |
| 25-12-02 | 2,034.00 kr | -0.44% | 102,482 |
| 25-12-01 | 2,043.00 kr | +0.20% | 162,397 |
Delayed Quote Nasdaq Copenhagen, December 05, 2025 at 11:20 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions
